Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-4145

2. Registrant Information.

Registrant Reference Number: PROSAR Case 1-16495690

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

07-AUG-08

5. Location of incident.

Country: UNITED STATES

Prov / State: WISCONSIN

6. Date incident was first observed.

07-AUG-08

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2596-147

Product Name: UltraGuard One Spot Flea Egg and Larvae Treatment fro Cats and Kittens

  • Active Ingredient(s)
    • (S)-METHOPRENE
      • Guarantee/concentration 2.9 %

7. b) Type of formulation.

Liquid

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The owner applied the product to the cat for a second time on 8/7/2008.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected

1

5. Sex

Male

6. Age (provide a range if necessary )

2

7. Weight (provide a range if necessary )

8.6

lbs

8. Route(s) of exposure

Skin

9. What was the length of exposure?

>2 hrs <=8 hrs / >2 h <=8 h

10. Time between exposure and onset of symptoms

>2 hrs <=8 hrs / > 2 h < = 8 h

11. List all symptoms

System

  • Respiratory System
    • Symptom - Panting
  • Gastrointestinal System
    • Symptom - Salivating excessively
  • Respiratory System
    • Symptom - Other
    • Specify - Unusual breathing
    • Symptom - Nose bleed
    • Specify - Pink tinged nasal discharge
  • General
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.

Yes

14. a) Was the animal hospitalized?

No

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Died

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-16499657: The reporter, a Veterinarian, called on 8/7/2008, to report exposure of a cat to a flea egg and larvae product containing the active ingredient Methoprene. According to the reporter, the owner applied the product to the cat approximately 6 hours prior to the call. This was the second time this product had been applied to the cat. After application, the owner noticed that the cat was breathing "funny", panting, and salivating. The owner washed the product off the cat at the application site with dish soap and water and immediately took the cat to the reporter┐s veterinary hospital. The cat presented panting with pink-tinged nasal discharge. A chest X-Ray showed a mild signs of possible respiratory infection or disease. Shortly after arriving, the cat died in the hospital. The owner declined the Veterinarian┐s recommendation for necropsy. The reporter, the attending Veterinarian, did not believe the cat┐s symptoms were related to product use. The safety profile of the product was discussed; the product has a low toxicity level when used according to labeled directions. It was relayed that the symptoms described along with sudden death would not be expected with routine product use.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Death

19. Provide supplemental information here